Adenoviral Conjunctivitis: Clinical Trials

5 trials for Adenoviral Conjunctivitis, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

2 completed, 1 terminated, 1 unknown, 1 withdrawn. 5 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 25Completed 2, Terminated 1, Unknown 1, Withdrawn 1

Follow Adenoviral Conjunctivitis: new trials by email Literature Review of Adenoviral Conjunctivitis trials Research Report on Adenoviral Conjunctivitis

Trials (filtered) newest first · largest first

All 5 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Trial to Evaluate the Efficacy and Safety of IVIEW-1201 in Acute Viral Conjunctivitis
IVIEW-1201, Placebo - Adenoviral Conjunctivitis
Phase 2CompletedIVIEW Therapeutics Inc.1352023-02-202025-10-15
OKG-0301 for the Treatment of Acute Adenoviral Conjunctivitis
OKG-0301 - Adenoviral Conjunctivitis
Phase 2UnknownOkogen2192019-02-112022-04-21
Efficacy and Safety of Iota-Carrageenan Eye Drops (NCX-4240)
Iota-Carrageenan, Carmellose - Adenoviral Conjunctivitis
Phase 2WithdrawnNicOx2017-01-012017-05-10
Efficacy and Safety of NVC-422 in the Treatment of Adenoviral Conjunctivitis
NVC-422 Solution, 0.3%, NVC-422 Vehicle Solution - Adenoviral Conjunctivitis
Phase 2CompletedNovaBay Pharmaceuticals, Inc.5002012-05-012015-05-28
An Evaluation of the Efficacy and Safety of AL-46383A Ophthalmic Solution for the Treatment of Adenoviral Conjunctivitis
AL-46383A Ophthalmic Solution, AL-46383A Ophthalmic Solution Vehicle - Adenoviral Conjunctivitis
Phase 2TerminatedAlcon Research4522009-06-012014-05-22

Narrower conditions

Conjunctivitis (2)  ·  Adenoviridae Infections (1)  ·  Eye Infections (1)

Broader conditions

Conjunctival Diseases (2)  ·  Eye Diseases (2)  ·  Infections (2)  ·  DNA Virus Infections (1)  ·  Virus Diseases (1)

Interventions

Carboxymethylcellulose Sodium (1)  ·  Carrageenan (1)

Sponsors

Alcon Research (1)  ·  IVIEW Therapeutics Inc. (1)  ·  NicOx (1)  ·  NovaBay Pharmaceuticals, Inc. (1)  ·  Okogen (1)

Countries

India (2)  ·  Australia (1)  ·  Brazil (1)  ·  Spain (1)  ·  Sri Lanka (1)  ·  United States (1)

Top investigators

Brigitte Duquesroix (1)  ·  David Stroman, Ph.D. (1)  ·  Sally Scheib (1)